Shoji Nagao

ORCID: 0000-0003-4031-8091 · 2 papers in corpus

other 2021

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

International journal of clinical oncology ·doi:10.1007/s10147-021-01914-y

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we exam…

article 2015

A case of endometrial cancer detected incidentally after a total laparoscopic hysterectomy for adenomyosis

·doi:10.5180/jsgoe.31.244

We present a case of endometrial cancer detected incidentally after a total laparoscopic hysterectomy for adenomyosis. A 45-year-old woman was referred to our department with the chief complaint of hypermenorrhea, abnormal genital bleeding,…